Bacillus Calmette Guerin (BCG)
immunotherapy has anti-tumorigenic effects against
bladder cancer. To improve the efficacy of BCG
therapy, we introduced the gene encoding the 65 kDa
heat shock protein (hsp) of Mycobacterium tuberculosis into a mouse
malignant melanoma cell line (B16). An expression vector harboring the 65 kDa
antigen gene was transfected into B16 using
Lipofectamine, then expression of the
antigen was confirmed by RT-PCR and Western blotting. Several cell lines expressing 65 kDa
antigen were established (B16/65 kDa). We also established a control cell line transfected with the vector alone (B16/con). All cell lines (B16, B16/con, B16/65 kDa) were injected intraperitoneally into syngeneic mice with or without BCG prior immunization and the development of
tumor ascites was examined. To analyze the mechanism of the anti-
tumor effect, CD4 T cells or CD8 T cells were depleted in vivo by administering the corresponding
monoclonal antibody. B16/65k Da expressed the 65 kDa hsp of M.
tuberculosis. The
tumor growth of B16/65 kDa was slightly retarded in naive mice, but significantly inhibited by BCG. The anti-
tumor effect was totally abrogated in mice deficient in CD4 T cells, suggesting that CD4 T cells are involved in this process. The 65 kDa hsp of M.
tuberculosis was expressed after gene transduction in a
malignant melanoma cell line and significantly enhanced the anti-
tumor effect of BCG
immunotherapy. CD4 T cells play an important role in this anti-
tumor effect.